Elevated levels of inflammation-related molecules within PDT-targeted tissue, such as NF-κB and cyclooxygenase-2 (COX-2), could reduce the antitumor effectiveness of PDT by facilitating survival of residual tumor cells, [18,19,20,21,22]. This evidence concerns the gene NFKB1 and neoplasm.